Location: Greenwich, CT
CIK: 0001577524 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value: $259M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARIAD PHARMACEUTICALS INC | 12,850,000 | $69.39M | 26.8% | $6.73 | — | COM | 04033A100 |
| DGX | QUEST DIAGNOSTICS INC | 775,000 | $47.03M | 18.2% | $46.05 | +6.6% | COM | 74834L100 |
| — | BIO-REFERENCE LABS INC | 1,280,984 | $35.94M | 13.9% | $27.20 | — | COM $.01 NEW | 09057G602 |
| A | AGILENT TECHNOLOGIES INC. | 460,000 | $26.21M | 10.1% | $37.20 | 0.0% | COM | 00846U101 |
| MRK | MERCK & CO INC NEW | 400,000 | $23.71M | 9.2% | $31.29 | +25.8% | COM | 58933Y105 |
| AMGN | AMGEN INC | 120,000 | $16.86M | 6.5% | $90.34 | +4.6% | COM | 031162100 |
| — | REPROS THERAPEUTICS INC | 1,132,367 | $11.21M | 4.3% | $16.90 | — | COM NEW | 76028H209 |
| — | VIVUS INC | 2,573,943 | $9.935M | 3.8% | $9.08 | — | COM | 928551100 |
| — | INTRA CELLULAR THERAPIES INC | 360,000 | $4.936M | 1.9% | $16.06 | — | COM | 46116X101 |
| ENTA | ENANTA PHARMACEUTICALS INC | 105,000 | $4.155M | 1.6% | $37.28 | +6.9% | COM | 29251M106 |
| — | KINDRED BIOSCIENCES INC | 390,000 | $3.608M | 1.4% | $14.71 | — | COM | 494577109 |
| — | AVEO PHARMACEUTICALS INC | 2,570,759 | $2.854M | 1.1% | $1.84 | — | COM | 053588109 |
| — | TARGACEPT INC | 630,000 | $1.594M | 0.6% | $4.63 | — | COM | 87611R306 |
| — | ONCONOVA THERAPEUTICS INC | 350,000 | $1.505M | 0.6% | $6.34 | — | COM | 68232V108 |